This study provides utility scores for non-muscle invasive bladder cancer (NMIBC) health states, associated with a significant health-related quality-of-life burden.

We found significant differences between utilities, except between High-Grade Recurrence and > 1-Year Post-cystectomy, there were also significant differences in utility scores by age and employment status.

These values address an existing gap in available data and can be used in cost-effectiveness models of current and newly developed treatments for bladder cancer.